GoodRx Holdings, Inc. (GDRX)

NASDAQ: GDRX · Real-Time Price · USD
4.570
+0.150 (3.39%)
At close: Jan 17, 2025, 4:00 PM
4.600
+0.030 (0.66%)
After-hours: Jan 17, 2025, 7:29 PM EST
3.39%
Market Cap 1.76B
Revenue (ttm) 790.39M
Net Income (ttm) -16.22M
Shares Out 384.80M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE 26.57
Dividend n/a
Ex-Dividend Date n/a
Volume 1,841,673
Open 4.420
Previous Close 4.420
Day's Range 4.380 - 4.610
52-Week Range 4.090 - 9.260
Beta 1.28
Analysts Buy
Price Target 8.75 (+91.47%)
Earnings Date Feb 27, 2025

About GDRX

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves ph... [Read more]

Sector Healthcare
IPO Date Sep 23, 2020
Employees 694
Stock Exchange NASDAQ
Ticker Symbol GDRX
Full Company Profile

Financial Performance

In 2023, GoodRx Holdings's revenue was $750.27 million, a decrease of -2.12% compared to the previous year's $766.55 million. Losses were -$8.87 million, -72.99% less than in 2022.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $8.75, which is an increase of 91.47% from the latest price.

Price Target
$8.75
(91.47% upside)
Analyst Consensus: Buy
Stock Forecasts

News

GoodRx CFO Karsten Voermann to Resign for Personal Reasons

GoodRx Holdings disclosed Monday (Jan. 13) that its chief financial officer, Karsten Voermann, submitted his resignation Tuesday (Jan. 7), effective Friday (Jan. 16). The company attributed the resign...

6 days ago - PYMNTS

GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California...

10 days ago - Business Wire

GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable an...

13 days ago - Business Wire

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health com...

27 days ago - CNBC

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the...

4 weeks ago - Business Wire

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “Endocrinologist...

4 weeks ago - Business Wire

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President an...

5 weeks ago - Business Wire

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That's according...

6 weeks ago - CNBC

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look a...

6 weeks ago - Business Wire

GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Sc...

2 months ago - Business Wire

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm

NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX)  breached t...

2 months ago - PRNewsWire

Harrow Launches Access and Affordability Program with Price Reductions for Branded Products

NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an innovative initiative to expand access and affordability...

Other symbols: HROW
2 months ago - Business Wire

GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript

GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript

2 months ago - Seeking Alpha

GoodRx Reports Third Quarter 2024 Results

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its fin...

2 months ago - Business Wire

GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement

Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair of phar...

Other symbols: CVS
2 months ago - PYMNTS

GoodRx to Participate in Upcoming Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the...

2 months ago - Business Wire

GoodRx Unveils New E-commerce Platform, Launches with Opill®

SANTA MONICA, Calif.--(BUSINESS WIRE)--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with Opill® as its lau...

2 months ago - Business Wire

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules ...

2 months ago - Business Wire

Ronald E. Bruehlman Joins GoodRx Board of Directors

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the e...

3 months ago - Business Wire

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

SANTA MONICA, Calif.--(BUSINESS WIRE)--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormo...

3 months ago - Business Wire

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

SAN FRANCISCO--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be able to use Affirm to pay over time for select medi...

3 months ago - Business Wire

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its thir...

3 months ago - Business Wire

GoodRx Holdings: Failing To Gain Much Traction

Today, we are circling back on GoodRx Holdings, which offers a platform for comparing prescription drug prices. The company also enables their customers to benefit from negotiated prices through GoodR...

3 months ago - Seeking Alpha

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS Pharmaceuticals, Inc. (“ARS Pharmaceuticals”...

4 months ago - Business Wire

GoodRX Subscription Revenue Down 8% but Active User Numbers Are Up

It was a mixed bag of growth and challenges for digital healthcare platform GoodRx during the second quarter. In reporting its second-quarter results Thursday (Aug. 8), GoodRx said monthly active user...

5 months ago - PYMNTS